A Need for UGPIV Standardization

Clinical Product Evaluation of UltraDrape

Simple and efficient: Standardizing ultrasound-guided peripheral insertions with barrier dressing cuts waste, saves time, costs less, and improves patient safety

Ultrasound-guided peripheral intravenous (UGPIV) catheter insertions are commonly used to establish intravenous access in patients with difficult vascular access.

Journal of the Association for Vascular Access: Research Finds Significant UGPIV Variation

Cost Effectiveness of UltraDrape for UGPIV

UltraDrape® in The Journal of the Association for Vascular Access Fall Issue "Survey of Ultrasound-Guided Peripheral Intravenous Access: A Report of Supply Usage and Variability Between Clinical Roles and Departments"

Infection Control Today: Ultrasound Transducers: Avoiding Gel Contamination and Using Proper Level Disinfection

AVA IV Quarterly: Optimizing Patient Outcomes and Savings: The Promise of Sterile Barrier and Dressings in UGPIV Insertions (Pages 26-29)

Healthcare Purchasing News: Maintaining an Equal Partnership between IP and Supply Chain

AVA Podcast: I Save That Podcast is supported by Parker Laboratories

Infection Control Today: Parker’s High-Level Disinfectant Foam Receives FDA de novo Clearance

Infection Control Today: Contamination of Point-of-Care Ultrasound Transducers Alarms Key Clinician

PSQH: The Podcast Episode 27 — Improving Patient Safety for Ultrasound-Guided IV insertions

Journal of the Association of Vascular Access: UltraDrape® in The Journal of the Association for Vascular Access Fall Issue "Survey of Ultrasound-Guided Peripheral Intravenous Access: A Report of Supply Usage and Variability Between Clinical Roles and Departments"

Infection Control Today: UltraDrape® in Infection Control Today Article "Better Barriers and Standardized Protocols: Improving UGPIV Safety"

Healthcare Purchasing News: UltraDrape® in Healthcare Purchasing News Article "Inserting Infection Prevention"

Real-World Strategies for Improving Patient Safety During Ultrasound-Guided PIV Insertions

Standardized Ultrasound-Guided PIV Insertions Improve Outcomes and Reduce Costs

Parker Laboratories to Introduce Groundbreaking Ultrasound Innovations at AVA 2023

AVA 2023: Standardized Protocols Ensure Patient Safety during Ultrasound-Guided PIV Insertions

Parker Laboratories to Launch Groundbreaking Ultrasound Innovations at ENA 2023

Sterile Barrier Dressing Increases Efficiency and Safety of UGPIV Insertions, Pilot Study Finds

Reducing Infection Risks for Ultrasound - Guided Percutaneous Performed by ED Nurses

State Agencies Grant Nationwide Access to Ultrasound Disinfectant from Parker Labs

FDA Grants De Novo Clearance to Tristel ULT™ as a High-Level Disinfectant for Ultrasound Applications

Parker Labs Partners with Tristel to Deliver
Ultrasound Disinfectant for U.S. Market

UltraDrape Makes Ultrasound-Guided PIV Insertions Safer, Easier and More Cost-Effective

Parker Laboratories Partners with Tristel

UltraDrape Reduces Cost of Ultrasound-Guided PIV Insertions, Increases Safety & Efficiency

Parker Labs Leads Investment in Solstice Pharmaceuticals' Innovative Ultrasound

Clinician Survey Reveals Significant Variation in Ultrasound-Guided PIV Insertion Practices

Protex® Disinfectants Can Be Used Against 2019 Novel Coronavirus

Survey Shows Patient Safety is Improved by Reducing Variability in Ultrasound-Guided PIV Insertions

Poll Finds Patient Safety is Threatened by Current Ultrasound-Guided PIV Insertion Techniques

UltraDrape® Barrier & Securement Dressing from Parker Laboratories Obtains CE Mark

Parker Laboratories Introduces World's First UGPIV Barrier and Securement Dressing

World's Ultrasound and Electromedical Industry Leader Celebrates 60th Anniversary

Medical Ultrasound Pioneer Expands New Jersey-Based Facilities

Parker Laboratories Unrelated to NJ Medical Device Manufacturer in Contaminated Ultrasound Gel Case

Honorary Doctor of Science Degree Conferred to Martin Buchalter, Founder, Parker Laboratories, Inc.

CDC Deems Protex® and Protex® ULTRA Suitable for Use in Suspected or Confirmed Cases of Ebola Virus Infection

Parker Laboratories Introduces Protex® ULTRA with Faster Kill Times and Expanded Pathogen Effectiveness

Parker Laboratories Introduces Newly Redesigned Thermasonic Gel Warmer

Parker Laboratories Expands Operating Space to Accommodate Growth

Parker Laboratories Products Remain Safe for Use...NOT in any way related to Newark, NJ Ultrasound Gel Seizure

Parker Laboratories is the Semi-Finialist of the 19th Annual New Jersey Family Business of the Year Award

Prudential Center Selects Protex^® as Exclusive Cleaner/Disinfectant for its Athletic Training Rooms